OGN vs SBRA · P/E 3.4, rev $3.02B vs P/E 29, rev $457.6M
Organon & Co (OGN) versus Sabra Healthcare REIT Inc (SBRA) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Sabra Healthcare REIT Inc (SBRA) is a reit - healthcare facilities company listed on NASDAQ.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SBRA revenue for 2026-06-30 was $457.6M. Net income was $15.7M. SBRA currently screens at market cap $4.55B and trailing P/E 28.7.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SBRA currently screens at market cap $4.55B and trailing P/E 28.7.
Not investment advice. Open the OGN and SBRA stock pages for the full models.
Not investment advice.